539871 logo

Thyrocare Technologies Limited Stock Price

BSE:539871 Community·₹64.0b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

539871 Share Price Performance

₹1,208.60
421.95 (53.64%)
10.8% undervalued intrinsic discount
₹1,355.00
Fair Value
₹1,208.60
421.95 (53.64%)
10.8% undervalued intrinsic discount
₹1,355.00
Fair Value
Price ₹1,208.60
AnalystConsensusTarget ₹1,355.00

539871 Community Narratives

AnalystConsensusTarget·Updated
Fair Value ₹1.36k 10.8% undervalued intrinsic discount

Franchise Expansion And PharmEasy Partnerships Will Secure Future Success

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative

Recent 539871 News & Updates

Thyrocare Technologies Limited Key Details

₹7.2b

Revenue

₹3.6b

Cost of Revenue

₹3.7b

Gross Profit

₹2.6b

Other Expenses

₹1.1b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
20.05
Gross Margin
50.74%
Net Profit Margin
14.69%
Debt/Equity Ratio
4.5%

Thyrocare Technologies Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet with reasonable growth potential.

1 Risk
2 Rewards

About 539871

Founded
1996
Employees
1822
CEO
Rahul Guha
WebsiteView website
www.thyrocare.com

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Indian Market Performance

  • 7 Days: 1.5%
  • 3 Months: -1.7%
  • 1 Year: -4.7%
  • Year to Date: 0.7%
The market is up 1.5% over the last week, with the Financials sector leading the way, up 2.3%. Longer term the market is actually down 4.7% over the past year. Earnings are forecast to grow by 16% annually. Market details ›